ALPHA-(4-CHLOROPHENYLIMINO)-P-CRESOL
|
- $29.8 - $503.39
- Product name: ALPHA-(4-CHLOROPHENYLIMINO)-P-CRESOL
- CAS: 3369-35-5
- MF: C13H10ClNO
- MW: 231.68
- EINECS:
- MDL Number:MFCD00029740
- Synonyms:ALPHA-(4-CHLOROPHENYLIMINO)-P-CRESOL;Phenol, 4-[[(4-chlorophenyl)imino]methyl]-;4-(((4-Chlorophenyl)imino)methyl)phenol
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 5MG
- 250mg
- 1 unit
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0122235
- Product description4-CHLORO-N-(4-METHOXYBENZYLIDENE)ANILINE 95.00%
- Packaging5MG
- Price$503.39
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberS684538
- Product descriptionALPHA-(4-CHLOROPHENYLIMINO)-P-CRESOL Aldrich
- Packaging250mg
- Price$29.8
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberS684538
- Product descriptionALPHA-(4-CHLOROPHENYLIMINO)-P-CRESOL AldrichCPR
- Packaging1 unit
- Price$32.7
- Updated2026-03-19
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | HCH0122235 | 4-CHLORO-N-(4-METHOXYBENZYLIDENE)ANILINE 95.00% | 5MG | $503.39 | 2021-12-16 | Buy |
| Sigma-Aldrich | S684538 | ALPHA-(4-CHLOROPHENYLIMINO)-P-CRESOL Aldrich | 250mg | $29.8 | 2024-03-01 | Buy |
| Sigma-Aldrich | S684538 | ALPHA-(4-CHLOROPHENYLIMINO)-P-CRESOL AldrichCPR | 1 unit | $32.7 | 2026-03-19 | Buy |
Properties
Boiling point :400.5±30.0 °C(Predicted)
Density :1.18±0.1 g/cm3(Predicted)
pka :8.58±0.15(Predicted)
Density :1.18±0.1 g/cm3(Predicted)
pka :8.58±0.15(Predicted)
Safety Information
| Symbol(GHS): |
![]()
|
||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | ||||||||||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|





